Statement re: Offer for Subscription ProVen VCT plc ProVen

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
37
Statement re: Offer for Subscription

ProVen VCT plc ProVen Growth and Income VCT plc 11 January 2019 Offer for Subscription

ProVen VCT plc and ProVen Growth and Income VCT plc (the “Companies”) announce that they have published a Prospectus (comprising a Securities Note, Registration Document and Summary) in respect of an offer for subscription to raise up to £60,000,000 by way of an issue of new ordinary shares ("New Ordinary Shares") in the Companies, with an over-allotment facility of up to a further £20,000,000, payable in full in cash on application (the “Offer”).

The Offer opens on 11 January 2019 and will close not later than 1.00 pm on 5 April 2019 in respect of the 2018/2019 Offer and not later than 1.00 pm on 30 April 2019 in respect of the 2019/2020 Offer, or as soon as the Offer is fully subscribed. The directors of each of the Companies may decide to extend the Offer in respect of their Company at their absolute discretion to a date no later than 10 January 2020.

Applicants (and/or their spouses) who had an existing shareholding in one of the Companies on 11 January 2019, and whose valid Application forms part of the first £5 million of valid Applications for each Company or is received by 1 p.m. on 15 February 2019 if £5 million of valid Applications for that Company have not been received by this date, will be entitled to additional New Ordinary Shares with an aggregate subscription price equivalent to 2% of the amount subscribed.

All other Applicants whose valid Application forms part of the first £5 million of valid Applications for each Company or is received by 1 p.m. on 15 February 2019 if £5 million of valid Applications for that Company have not been received by this date, will be entitled to additional New Ordinary Shares with an aggregate subscription price equivalent to 1% of the amount subscribed.

The subscription price of the Additional Shares will be met by the Manager.

Pursuant to an agreement dated 11 January 2019 between, inter alia, the Companies and Beringea LLP, the Companies investment manager ("Beringea"), Beringea will receive a fee (the "Fee") for acting as promoter of the Offer equal to five and a half (5.5) per cent. of the gross funds raised under the Offer from applications received directly from investors and three (3) per cent. of the gross funds raised under the Offer from applications received through execution-only brokers and financial advisers. Out of the Fee Beringea will pay all costs agreed between the Companies and Beringea, including charges and expenses of, or incidental to, the Offer.

Pursuant to a deed of variation dated 11 January 2019, the investment management agreement (the "ProVen IMA") between ProVen VCT plc and Beringea will be varied as a result of the Offer to provide for an increase in the compensation payable to Beringea in the event of an early termination of the ProVen IMA. The maximum amount of such compensation payable is the sum of £1,900,000.

Pursuant to a deed of variation dated 11 January 2019, the investment management agreement (the "PGI IMA") between ProVen Growth & Income VCT plc and Beringea will be varied as a result of the Offer to provide for an increase in the compensation payable to Beringea in the event of an early termination of the PGI IMA. The maximum amount of such compensation payable is the sum of £2,500,000.

The Fee and the amendments to the ProVen IMA and the PGI IMA are smaller related party transactions between each of the Companies and Beringea under Listing Rule 11.1.10.

To obtain a copy of the Securities Note private investors and Financial Advisers should call the investment manager, Beringea, on 020 7845 7820 or 0845 686 0225. A downloadable version of the Securities Note is also available from www.provenvcts.co.uk .

A copy of the Prospectus is available, free of charge, from the registered office of the Company or from:

Beringea LLP 39 Earlham Street London WC2H 9LT

Copies of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for viewing online at the following web-site address:

http://www.hemscott.com/nsm.do

For further information please contact:

Shane Elliott on 020 7845 7820

Beringea LLP Company Secretary Telephone 020 7845 7820

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing K-12 Education: Five Star's Virtual Help Desk

Updated Category News Views 159

Five Star Technology Solutions' Anniversary Celebration Five Star Technology Solutions proudly commemorates three years since the launch of its innovative Virtual Help Desk (vHD), a service dedicated to enhancing K–12 education. This powerful tool has redefined how schools and districts obtain technical support, resulting in increased efficiency and cost savings, while...

Continue Reading
Exploring the Dynamics of Small-Cap Investments in RVT

Updated Category News Views 181

Understanding Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as the oldest and largest closed-end fund dedicated to small-cap stocks. By focusing on these smaller companies, the trust has carved out a unique niche in the investment landscape. Key Highlights The fund enjoys an impressive weekly trading volume of around 974,286 shares, reflecting strong...

Continue Reading
Projected Growth of Peripheral Intravenous Catheters Market

Updated Category News Views 215

Overview of the Peripheral Intravenous Catheters Market The peripheral intravenous catheters (PIVCs) market is on track to reach a striking valuation of USD 10.9 billion by 2032. This expected growth is primarily propelled by the rising number of both elective and emergency surgeries conducted around the world. Increasing Need for Intravenous Access Every year, over 310...

Continue Reading
Vaxart Announces New Lead Independent Director Appointment

Updated Category News Views 122

Appointment of W. Mark Watson SOUTH SAN FRANCISCO, Calif. — Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company, proudly announces the appointment of W. Mark Watson as its Lead Independent Director. With a wealth of knowledge spanning over 50 years in the field of accounting and business, Mr. Watson is set to significantly enhance the strategic direction...

Continue Reading
Legal Review of Potential Securities Fraud by Stellantis N.V.

Updated Category News Views 176

Understanding the Investigation into Stellantis N.V. There is an ongoing investigation regarding potential securities fraud claims against Stellantis N.V. (NYSE: STLA). This inquiry arises due to allegations that the company may have made inaccurate statements about its business performance and future prospects. The focus of the investigation highlights key elements of...

Continue Reading